05:21 AM EDT, 07/16/2026 (MT Newswires) -- Eli Lilly (LLY.F) is reportedly negotiating an acquisition of psychedelic drugmaker AtaiBeckley, Bloomberg News reported Thursday, citing people familiar with the matter. The potential acquisition, which could be announced as soon as this week, would expand the US-based drugmaker's neuroscience portfolio as it looks to enter the psychedelics market, the report said. Eli Lilly did not immediately respond to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.